Large Bowel Flashcards
(66 cards)
Microscopic colitis biopsy findings
lymphocytic or collagenous colitis
Layers of the bowel impacted by UC (2)
mucosa
submucosa
Chemo for colorectal cancer
FOLFOX
Components of FOLFOX (3)
5-fluorouracil
leucovorin
oxaliplatin
Antibiotics for uncomplicated diverticulitis (2)
ciprofloxacin + metronidazole
IBS-C fiber recommendations
increase intake
IBS-D fiber recommendations
decreased intake
Rome IV IBS criteria
1) symptoms lasting at least 6 months
2) occurring at least 1 day/week
3) for the past 3 months
Chronic diarrhea duration
> 4 wks
Serum ferritin indicative of anemia in chronic disease
> 100
Number of recurrences to consider FMT
2-3
Success rate of FMT
> 90%
Polyp size to use snare polypectomy
< 1 cm
Components for Mayo score (4)
stool frequency
rectal bleeding
endoscopic findings
physician global assessment
Mayo score
Stool Frequency:
0: Normal
1: 1-2 stools more than normal
2: 3-4 stools more than normal
3: ≥5 stools more than normal
Rectal Bleeding:
0: None
1: Streaks of blood in stool
2: Obvious blood in stool
3: Passing blood alone
Endoscopic Findings:
0: Normal or inactive disease
1: Mild disease (erythema, decreased vascular pattern, mild friability)
2: Moderate disease (marked erythema, lack of vascular pattern, friability)
3: Severe disease (spontaneous bleeding, large ulcers)
Physician’s Global Assessment:
0: Normal
1: Mild disease
2: Moderate disease
3: Severe disease
Polyp size that EMR is indicated
> /= 2 cm
Diagnosis of toxic megacolon
colonic dilation > 6 cm on x-ray w/ systemic toxicity
Toxic megacolon treatment
IV steroids
cipro + flagyl
surgery if no improvement in 24-48 hours
UC vs Crohn’s histology
UC - crypt abscesses, mucosal inflammation
Crohn’s - noncaseating granulomas, transmural inflammation
FAP surgical management
colectomy by age 25 if multiple polyps
Genetic testing for Lynch Syndrome (3)
MLH1
MSH2
MSH6
Peutz-Jeghers genetic mutation
STK11 gene
TNF inhibitor indicated for FISTULIZING Crohn’s
infliximab (remicade)
FAP inheritance pattern
autosomal dominant